±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1048  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

hongyangu

Í­³æ (СÓÐÃûÆø)

[½»Á÷] ·ÖÏí:ͦºÃµÄÊý¾Ý¿â

´ÓÍøÉÏÕªµÄÊý¾Ý¿â
ADIS R&D Insight £¨ADISÒ©ÎïÑз¢Êý¾Ý¿â£©
     ADISÒ©ÎïÑз¢Êý¾Ý¿âÊÇAdis International¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿âµÄÐÅÏ¢À´Ô´ InPharma¡¢Reactions¡¢PharmacoEconomics & Outcomes News¡¢Clinical Trial InsightsµÈ2300ÖÖÒÔÉϵÄÒ©Îï¡¢ÉúÎïרҵÆÚ¿¯£¬¹ú¼Ê»áÒ飬¹«Ë¾Ä걨ºÍÐÂÎű¨µÀµÈ¹«¿ª×ÊÁϺͷǹ«¿ª×ÊÁÏ¡£Êý¾Ý¿âÄÚÈݰüÀ¨Ã¿ÖÖÒ©Æ·µÄÆÕͨÃû£¬Í¬ÒåÃû£¬ÉÌÆ·Ãû£¬¿ª·¢¹«Ë¾, ¹ú¼Ò¼°¿ª·¢½×¶Î£¬ËùÓÐȨÐÅÏ¢£¬·åÆÚÏúÊ۶רÀûʧЧÆÚ£¬²»Á¼Ê¼þ, Ò©Àíѧ£¬Ò©¶¯Á¦Ñ§£¬Ò©Ð§Ñ§£¬¸±·´Ó¦£¬ÖÎÁÆÊµÑ飬¿ª·¢ÀúÊ·£¬×¢²áÐÅÏ¢ºÍ²Î¿¼ÎÄÏ׵ȵȡ£

IMS R&D Focus £¨IMSÒ©ÎïÑз¢Êý¾Ý¿â£©
     IMSÒ©ÎïÑз¢Êý¾Ý¿âÊÇIMS HEALTH¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿âÆ«ÖØÒ©ÎïµÄÉÌÒµÐÅÏ¢£¬ÐÅÏ¢À´Ô´ÓÚÒ©Î﹫˾µ÷ÑС¢¸ß²ã·Ã̸ºÍ¹Ù·½·¢²¼µÄ×ÊÁÏ£¬»¹°üÀ¨Ò»Ð©Ò½Ñ§ÆÚ¿¯¡¢¹ú¼Ê»áÒ飬¿ÆÑ§ÂÛÎĺÍרÀûÎÄÏ×µÈÊý¾Ý¿âÄÚÈݰüÀ¨Ã¿ÖÖÒ©Æ·µÄÊôÃû¡¢Ò©³§±àºÅ¡¢CAS×¢²áºÅ¡¢»¯Ñ§Ãû³Æ¡¢Í¬Òå´Ê¡¢ÖÎÁÆËµÃ÷¡¢×¨ÀûÎÄÕª¡¢·¢Õ¹ÀúÊ·¡¢ÊÀ½ç·¶Î§·¢Õ¹µÄ×îн׶Ρ¢ÉÌҵDZÁ¦¡¢¹«Ë¾»î¶¯¡¢¿ÆÑнøÕ¹ºÍרÀûÐÅÏ¢¡£

Pharmaproject £¨PharmaprojectÒ©Îï×ÛºÏÐÅÏ¢Êý¾Ý¿â£©
     PharmaprojectÒ©Îï×ÛºÏÐÅÏ¢Êý¾Ý¿âÊÇÖøÃûµÄPJB³ö°æ¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿âµÄÐÅÏ¢À´Ô´°üÀ¨·Ç¹«¿ªÇþµÀºÍ¹«¿ªÇþµÀ£¬·Ç¹«¿ªÇþµÀÀ´×ÔÓëÒ©Î﹫˾Ïà¹ØÈËÔ±µÄ·Ã̸£¬¹ú¼Ê»áÒéºÍ¸÷ÖÖµ÷Ñл£»¹«¿ªÇþµÀ°üÀ¨ÆÚ¿¯¡¢Ñ§Êõ×ÊÁϺͻáÒéÂÛÎĵÈÎÄÏס£Êý¾Ý¿âÄÚÈݰüÀ¨ÕýÔÚÑÐÖÆµÄÒ©Æ·£¬ºÍÒѾ­¹ã·ºÍ¶·ÅÊг¡µÄÒ©Æ·£¬ÒÔ¼°ÓÉÓÚ¶¾ÐÔ»òÉÌÒµ¶øÖÕÖ¹·¢Õ¹µÄÒ©Æ·Êý¾Ý£¬Êý¾Ý¼Ç¼°üº¬ÐÐÒµÃû³Æ¡¢»¯Ñ§Ãû³ÆºÍͬÒå´Ê¡¢ÖÎÁÆËµÃ÷¡¢Ò©Ñ§»úÀí£¬·¢Ðй«Ë¾ÓëµÇ¼ÇºÅ¡¢·¢Õ¹×´¿öµÈ¡£

Derwent World Patents Index £¨DerwentרÀûÊý¾Ý¿â£©
     DerwentרÀûÊý¾Ý¿âÊÇThomson Derwent¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿âÐÅÏ¢À´Ô´ÓÚÈ«Çò¸÷´ó֪ʶ²úȨ»ú¹¹£¬Ïêϸ¼ÇÔØÁ˳¬¹ý1ǧ1°ÙÍòÏî·¢Ã÷רÀûµÄ»ù±¾ÐÅÏ¢¡£Ã¿Ìõ¼Ç¼³ýÁ˶¼°üº¬Ïà¹ØµÄͬ×åרÀûÐÅÏ¢£¬»¹°üÀ¨Óɸ÷¸öÐÐÒµµÄ¼¼Êõר¼Ò½øÐÐÖØÐ±àдºóµÄרÀûÐÅÏ¢£¬ÈçÐÂÓ±ÐÔ¡¢¼¼Êõ¹Ø¼ü¡¢ÓŵãµÈ¡£¸ÃÊý¾Ý¿âµÄÖØµãÔÚÓÚרÀûµÄÖØÐ¸ÄдºÍÐÞ¸´£¬°ÑÄ£ºýµÄ¼¼ÊõÐÅÏ¢Ã÷È·»¯£¬°ÑÈß³¤¸´ÔÓµÄרÀûÐÅÏ¢¼òµ¥»¯£¬·½±ãÐÅÏ¢ÈËÔ±Á˽âºÍÕÆÎÕרÀûµÄºËÐÄÐÅÏ¢¡£

IMS Patent Focus £¨IMSÒ©ÎïרÀûÊý¾Ý¿â£©
     IMSÒ©ÎïÑз¢Êý¾Ý¿âÊÇIMS HEALTH¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿âµÄÐÅÏ¢À´Ô´ÓÚ¸÷¹úרÀûÎÄÏ׺ÍÏà¹ØµÄ»¯Ñ§×ÊÔ´£¬ÌṩÁ˳¬¹ý1,000ÖÖÉÌÒµÒ©Æ·¼°ÆäÏà¹Ø²úÆ·µÄרÀûÉêÇë×´¿ö£¬Êг¡¶¯Ì¬ºÍIIIÆÚÁÙ´²ÊÔÑéÖ®ºóµÄÐÅÏ¢£¬°üÀ¨Ò©Æ·µÄÊôÃû¡¢Ò©³§±àºÅ¡¢CAS×¢²áºÅ¡¢»¯Ñ§Ãû³Æ¡¢Í¬Òå´Ê¡¢ÖÎÁÆËµÃ÷¡¢×¨ÀûÎÄÕª¡¢·¢Õ¹ÀúÊ·¡¢ÊÀ½ç·¶Î§·¢Õ¹µÄ×îн׶Ρ¢ÉÌҵDZÁ¦ºÍ¹«Ë¾»î¶¯¡£ÖصãÔÚÒ©ÎïרÀûµÄÈ«ÇòÉêÇë×´¿ö¡£

INPADOC/Family and Legal Status £¨INPADOCͬ×åרÀû/·¨ÂÉ״̬Êý¾Ý¿â£©
     INPADOCͬ×åרÀû/·¨ÂÉ״̬Êý¾Ý¿âÊÇÅ·ÖÞרÀû¾ÖµÄ²úÆ·¡£Êý¾ÝÀ´×Ô66¸ö¹ú¼ÒºÍ×éÖ¯µÄרÀûÐÅÏ¢¡£¼Ç¼ÄÚÈݳýÁËÏà¹Ø×¨ÀûÍêÕûµÄͬ×åרÀû£¬»¹°üº¬27¸ö¹ú¼ÒµÄÏêϸ·¨ÂÉ״̬¼Ç¼¡£¸ÃÊý¾Ý¿âÖØµãÔÚרÀûµÄÈ«Çòͬ×åרÀû¼°×¨ÀûµÄÏêϸ·¨ÂÉ״̬¡£

Prous Science Drugs of the Future £¨Prous ScienceδÀ´Ò©Î
     Prous ScienceδÀ´Ò©ÎïÊý¾Ý¿âÊÇProus Science¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿â±¨µÀ´¦ÓÚ¸÷ÖÖÑо¿½×¶ÎµÄÒ©Îï½øÕ¹£¬´Ó¿ªÊ¼ÑÐÖÆ¡¢ÁÙ´²ÊÔÑéµ½ÉÏÊеÄÐÅÏ¢£¬°üÀ¨Ò©ÎïµÄÖÆ±¸·½·¨¡¢Ò©Àí¡¢¶¾Àí¡¢ÁÙ´²ÁÆÐ§¼°Êг¡ÐÅÏ¢µÈ¡£ÌṩҩÎïµÄ½á¹¹Ê½¡¢CASµÇ¼ÇºÅ¡¢ÁÙ´²Ñо¿ºÍÖÆÔìÉÌ¡£

Prous Science Drugs Data Report £¨Prous ScienceÒ©Îﱨ¸æ£©
     Prous ScienceÒ©Îﱨ¸æÊý¾Ý¿âÊÇProus Science¹«Ë¾µÄ²úÆ·¡£¸ÃÊý¾Ý¿â²àÖØÒ©ÎïµÄ»¯Ñ§¡¢Ç°ÆÚÁÙ´²·½ÏòºÍרÀûÐÅÏ¢£¬°üº¬65,000¸ö¾ßÓÐÉúÎï»îÐÔµÄÎïÖʼǼ£¬²¢ÇÒÿÄêÓÐÔ¼10,000¸ö¼Ç¼¼ÓÈë¡£Êý¾ÝÄÚÈݰüÀ¨Ò©ÎïµÄÑз¢ÐÅÏ¢¡¢Êг¡ÐÅÏ¢¡¢ÈÏÖ¤ÐÅÏ¢£¬¼ÇÔØµÄʱ¼ä´ÓרÀûÉêÇë½×¶Î¿ªÊ¼µ½ÉÏÊÐÕû¸öÒ©Î↑·¢Ñ­»·¡£

Biosis Preview £¨ÉúÎïѧÎÄÏ׿⣩
     ÄÚÈÝÏ൱ÓÚÓ¡Ë¢±¾ÃÀ¹ú¡¶ÉúÎïѧÎÄÕª¡·£¨BA£©ºÍ¡¶ÉúÎïѧÎÄÕª×ÛÊö¡¢¼¼Êõ±¨¸æ¡¢»áÒéÎÄÏס·£¨BA/RRM£©ÒÔ¼°BA/RRM 1980Äê´´¿¯Ê±µÄǰÉí¼ìË÷¿¯Îï¡¶ÉúÎïÑо¿Ë÷Òý¡·£¨Biobesearch Index£©¡£ÆäÖÐBAÿÄêÓÐ35ÍòÌõ¼Ç¼£¬Õª×Ô5,000ÖÖԭʼÆÚ¿¯ºÍ׍ָ£»BA/RRMÿÄêÓÐ20ÍòÌõ¼Ç¼£¬Õª×Ô»áÒéÎÄÕª¡¢×ÛÊö¡¢Í¼Êé¡¢Ôý¼Ç¡¢ÊéÐÅ¡¢¾«Ñ¡µÄÑо¿»ú¹¹ºÍÕþ¸®²¿Ãŵı¨¸æºÍÑо¿±¨µÀ£¬ÒÔ¼°1986-1989Äê¼äµÄÃÀ¹úרÀû¡£

EMBASE £¨ºÉÀ¼Ò½Ñ§ÎÄÕª£©
     EMBASEÒѱ»ÈÏΪÊÇÊÀ½çÉϹØÓÚÈËÀàҽѧºÍÏà¹ØÑ§¿ÆÎÄÏ×µÄÒ»ÖÖÖØÒªµÄ×ÛºÏÐÔµÄË÷Òý£¬Ã¿ÄêÊÕ¼50ÍòÌõ¼Ç¼£¬ÆäÖÐ80%¸½ÓÐÎÄÕª¡£ºÍÆäËüҽѧÎÄÕª²»Í¬µÄÊÇ£¬¸ÃÊý¾Ý¿âÊÕ¼Á˸ü¶àҩѧ·½ÃæµÄÐÅÏ¢£¬50£¥ÒÔÉϵÄÄÚÈÝÀ´Ô´ÓÚÅ·ÖÞµØÇøµÄÆÚ¿¯¡£EMBASE¶ÔÿһÌõ¼Ç¼¶¼½øÐÐÁË·ÖÀ࣬ҽѧÑо¿×¨¼Ò»¹¿ÉÒÔʹÓÃEMTREEÖеĹؼü´Ê²éÕÒËùÐèÎÄÏ×£¬EMTREEÊÇÒ»ÖֱȽÏÏȽøµÄ·ÖÀà±íºÍ¿É¿Ø´Ê»ã±í£¬ÓÉ46,000¸ö´ÊÓïºÍ20Íò¸öͬÒå´Ê×é³É£¬É漰ҩѧ¡¢¶¾Îï¡¢ÁÙ´²¡¢ÊµÑéҽѧ¡¢ÉúÎï¡¢¹«ÎÀ¡¢»·¾³¡¢¾«Éñ¡¢·¨Ò½¡¢ÉúÒ½µÈÖî¶àѧ¿Æ¡£

International Pharmaceutical Abstracts £¨¹ú¼ÊҩѧÎÄÕª£©
     ÌṩÁËËùÓйØÓÚÒ©ÎïµÄ·¢Õ¹×´¿ö¡¢Ê¹ÓÃÇé¿ö£¬ÒÔ¼°×¨¿ÆÒ©ÎïʵÑé·½ÃæµÄÐÅÏ¢¡£ÊÕ¼·¶Î§Éæ¼°µ½Ò»Ð©¹ú¼ÒµÄҩѧÆÚ¿¯£¬ÕâЩÆÚ¿¯¶¼¾ßÓÐͳ³ï¹æ»®¡¢Îȶ¨µÄ×ʽðºÍÈËÁ¦¡¢¹Ì¶¨µÄ·½ÕëÒÔ¼°·¨ÂÉ×÷±£Õϵȡ£ÊÕÕªÄÚÈݰüÀ¨Ò©Ñ§ÁìÓòµÄÁÙ´²Êµ¼ù¡¢ÀíÂÛ¡¢¾­¼Ã¡¢¿ÆÑ§µÈ·½Ã棬ÓйØÁÙ´²Ñо¿µÄÎÄÕª°üÀ¨Ñо¿Éè¼Æ¡¢²¡ÈËÊýÁ¿¡¢¼ÁÁ¿¡¢¼ÁÐÍ¡¢¼ÁÁ¿±íµÈ¡£
     Ö÷ÌⷶΧ£ºÒ©Î︱×÷Óá¢ÉúÎïÒ©Àíѧ¡¢Ò©Îï·ÖÎö¡¢Ò©ÎïÆÀ¹À¡¢Ò©ÎïÏ໥×÷Óá¢Ò©Îï´úлºÍÌåÄÚ·Ö²¼¡¢Ò©ÎïÎȶ¨ÐÔ¡¢ÀúÊ·¡¢ÐÅÏ¢½øÕ¹ºÍÎÄÏ×£»¹«¹²Ò©ÎïʵÑé¡¢µ÷²éÑо¿µÄÒ©Îï¡¢Á¢·¨¡¢·¨Âɺͷ¨¹æ£»·½·¨Ñ§ºÍÒ©Îï²âÊÔ¡¢Ò©Îﻯѧ¡¢ÖÆÒ©Ñ§¡¢Ò©Îï¾­¼Ãѧ¡¢ÉúÎïѧ¡¢ÖÆÒ©ÊÔÑé¡¢Ò©Àíѧ¡¢Éç»áѧ¡¢¾­¼ÃѧºÍÂ×Àíѧ¡¢¶¾Àíѧ¡£

Pharmaceutical News Index £¨Ò©Ñ§ÐÂÎÅË÷Òý£©
     ÌṩҩƷ¡¢»¯×±Æ·¡¢Ò½ÁÆÉ豸ºÍÏà¹ØÎÀÉúÁìÓòÄÚµÄ×îÐÂÏûÏ¢¡£
     Ö÷ÌⷶΧ£ºÊ³Æ·ºÍÒ©Æ·¹ÜÀí³·Ïû¡¢ÎÀÉú·¨¹æºÍÕþ²ßÖÆ¶¨¡¢Ò©Æ·Ñо¿¡¢¹ñÍâ¼°Ö¸¶¨ÏúÊÛÊг¡¡¢Ò©Îï¼°É豸µÄÅú×¼¡¢ËßËϼ°·¨Í¥ÌÖÂÛ¡¢Êг¡·ÖÎö¡¢ÉúÎï¼¼Êõ¸ÄÔì¡¢½øÕ¹¡¢ÊÞÒ½Ò©Æ·¡¢¼ÒÐó¼²²¡ÐÂÎÅ¡¢ÈËʱ䶯¡¢ÆóÒµ²ÆÕþÐÅÏ¢¡¢ÐÂÐÍÒ©Æ·ÉêÇë¼°Åú×¼¡¢ÊÕ»ñ¼°ºÏ²¢¡¢Õþ¸®ÆõÔ¼¡¢ÁªºÏ·çÏÕ¡¢¹ã¸æÔ˶¯µÈ¡£

Medline £¨ÃÀ¹úҽѧÎÄÕª£©
     ÓÉÃÀ¹ú¹úÁ¢Ò½Ñ§Í¼Êé¹ÝÌṩ¡£ÆäÄÚÈÝÏ൱ÓÚÈýÖÖÓ¡Ë¢±¾£ºÃÀ¹ú¡¶Ò½Ñ§Ë÷Òý¡·¡¢¡¶ÑÀ¿ÆÎÄÏ×Ë÷Òý¡·¡¢¡¶¹ú¼Ê»¤ÀíË÷Òý¡·¡£1975ÒÔºóµÄ¼Ç¼ÓÐ59£¥´øÓм×ÔÔ­ÎĵÄÎÄÕª¡£1975ÄêÒÔǰµÄ¼Ç¼¶¼ÎÞÎÄÕª£»1985ÄêÖÁ½ñÔ¼ÓÐ69%µÄ¼Ç¼¸½ÓÐÎÄÕª¡£Ã¿ÄêÐÂÔö400,000¶àÍòÌõ¼Ç¼£¬ÆäÖÐ85£¥ÊÇÓ¢ÎÄ¡£

CancerLIT £¨°©Ö¢ÎÄÏ×Êý¾Ý¿â£©
     ÓÉÃÀ¹ú¹úÁ¢°©Ö¢Ñо¿ËùÌṩ¡£´Ó1963ÄêÖÁ½ñ£¬¸ÃÊý¾Ý¿âµÄ¼Ç¼ժ×Ô°©Ö¢Ñо¿·½ÃæµÄ³ö°æÎï¡£´ó²¿·Ö¼Ç¼ÓÐÎÄÕª£¬ËùÓмǼ¶¼ÓÐÒýÎÄÐÅÏ¢ºÍÆäËûÄÚÈÝ£¨ÈçÂÛÎÄÀàÐͺÍÓïÖÖ£©¡£´Ó1983Äê6Ô¿ªÊ¼£¬CancerLITÊý¾Ý¿âÄÚÈÝÓÐËù¸Ä±ä£¬MedlineÖÐÓйذ©Ö¢µÄÄÚÈÝÈ«²¿ÊÕ¼ÈëCancerLITÊý¾Ý¿âÖС£¼ìË÷1980Äê1ÔÂÆðÊÕÈëCancerLITÊý¾Ý¿âµÄ¼Ç¼£¬ÐèʹÓÃMeSH±í¡£1983Äê֮ǰÊÕ¼µÄ¼Ç¼¾ùÎÞÎÄÕª£¬1983Äê6ÔÂÒÔºóÊÕ¼µÄ¼Ç¼75£¥¸½ÓÐÎÄÕª¡£
     Ö÷ÌⷶΧ£ºÊÔÑéÐÔºÍÁÙ´²Ö×ÁöÖÎÁÆ£»ÌåÄÚºÍÌåÍâ°©Ö¢µÄÉúÎﻯѧ¡¢ÃâÒßѧ¡¢ÉúÀíѧºÍÉúÎïѧ£»ÓÕ·¢°©Ö¢µÄ»¯Ñ§¡¢²¡¶¾ºÍÆäËüÒòËØ£»Ö°©¼ÁµÄ½á¹¹¡¢Í»±äÒò×ÓµÄÑо¿¡¢Í»±äÒò×ÓµÄÊÔÑé¡¢µ¼ÖÂϸ°û·ÖÀëµÄÉú³¤Òò×ÓºÍÆäËüÒòËØ¡£

Diogenes FDA Regulatory Updates £¨µÏ°Â½ÜÄá˹ÃÀ¹úʳƷÓëÒ©Îï·¨¹æÐÅÏ¢£©
     ÌṩÎÀÉú±£½¡¹¤ÒµËùÐèÒªµÄÃÀ¹úʳƷÓëÒ©Æ·¹ÜÀí·½ÃæµÄÐÅÏ¢£¬°üÀ¨ÓëÒ©ÎïºÍÒ½ÁÆÉ豸ÓйصÄÃÀ¹ú¹æÕ¡¢·¨¹æµÄÐÂÎű¨µÀºÍ·Ç³ö°æÎÄÏ×£¬²¢Ìá¹©ÕæÊµµÄ¡¢ÊÊʱµÄÈ«ÎÄ×ÊÁÏ£¬ÀýÈçÒÑ»ñ×¼²úÆ·µÄĿ¼¡¢É豸µÄ¾­Ñ鱨¸æ¡¢ÌØÖÖ²úÆ·ÉóÅú¹ý³ÌÖеÄÎļþ¡¢¹æÕ·¨¹æÖƶ¨µÄ»Ø¹ËÐÔÎÄÏ׵ȡ£

Current Biotechnology Abstracts £¨½üÆÚÉúÎï¼¼ÊõÎÄÕª£©
     ÄÚÈÝÏ൱ÓÚÓ¢¹ú»Ê¼Ò»¯Ñ§»áÌṩµÄÓ¡Ë¢±¾¡¶½üÆÚÉúÎï¼¼Êõ¡·£¬°üÀ¨×Ô1983ÄêÒÔÀ´µÄËùÓÐÎÄÏס£Ã¿Ìõ¼Ç¼ÓÐÏêϸµÄÌ⼡¢ÎÄÕª£¬²¢ÌṩÖ÷Ìâ¡¢»¯Ñ§ÎïÖÊ¡¢¹«Ë¾µÈ¼ìË÷Èë¿Ú¡£ÎÄÏ×ÀàÐͰüÀ¨ÉÌÒµÐÂÎÅ¡¢¿Æ¼¼ÎÄÏ×£¨°üÀ¨×¨Àû£©ÒÔ¼°Ò»°ãÐÅÏ¢£¨½üÆÚ´óʼþ¡¢ÐÂÊéͨ±¨µÈ£©¡£
Ö÷ÌⷶΧ£º»ùÒò¿ØÖÆ£¬µ¥¿Ë¡¿¹Ì壬¹Ì¶¨Ï¸°ûºÍø£¬µ¥Ï¸°ûµ°°×£¬Ò©Àíѧ¡¢È¼ÁÏ¡¢Å©Òµ¡¢»¯Ñ§¡¢Ê³Æ·ºÍÆäËü¹¤ÒµÖеķ¢½Í¼¼Êõ¡£

Derwent Biotechnology Abstracts £¨µÂÎÂÌØÉúÎï¼¼ÊõÎÄÕª£©
     ÓÉÊÀ½çÖøÃûµÄÓ¢¹úµÂÎÂÌØÐÅÏ¢¹«Ë¾Ìṩ£¬ÊÕ¼ÁËÉúÎï¼¼ÊõÑо¿ÁìÓòÄÚµÄ×ÛºÏÐÔ³ö°æÎï¡¢¿Æ¼¼ÆÚ¿¯ºÍרÀûÎÄÏס£ÄÚÈÝÉæ¼°ÉúÎï¼¼ÊõµÄËùÓз½Ã棬°üÀ¨ÒÅ´«¹¤³Ì¡¢ÉúÎﻯѧ¹¤³Ì¡¢·¢½Í¼¼Êõ¡¢Ï¸°û½á¹¹¡¢·ÏÎïÏû»Ù¡£Ã¿ÈÕÐÂÔö1000µ½1200ƪÎÄÏס£Ã¿Ìõ¼Ç¼ԼÓÐ200¸ö´ÊµÄÎÄÕª¡£ÎÄÏ×ÀàÐÍÓÐÆÚ¿¯ÂÛÎĺÍרÀû£¬ºóÕßÔ¼Õ¼27%¡£¸Ã¿âÏ൱ÓÚµÂÎÂÌØÐÅÏ¢¹«Ë¾µÄͬÃûÓ¡Ë¢±¾³ö°æÎï¡£

The Merck Index Online £¨Ä¬¿ËË÷ÒýÁª»ú°æ£©
     ¡¶Ä¬¿ËË÷Òý¡·ÊÇÒ»ÖÖÊÀ½çÖøÃûµÄÓйػ¯Ñ§ÎïÖÊ¡¢Ò©Æ·¼°ÉúÎïÖÆÆ·µÄ°Ù¿ÆÈ«Êé¡£¸Ã¿âÊÇÓ¡Ë¢±¾¡¶Ä¬¿ËË÷Òý¡·ÃÀ¹ú°æµÚ12°æµÄÁª»ú°æ¡£Êý¾Ý¿âÖеÄÿһÌõ¼Ç¼£¨¼´°Ù¿ÆÈ«ÊéµÄÿһÌõÄ¿£©ÆÀÊöÒ»ÖÖµ¥Ò»´æÔڵĻ¯Ñ§ÎïÖÊ»òÒ»×é·Ç³£ÃÜÇÐÏà¹ØµÄ»¯ºÏÎï¡£
¼Ç¼µÄÄÚÈݰüÀ¨£º·Ö×ÓʽºÍ·Ö×ÓÁ¿¡¢±ê×¼»¯Ñ§Ãû³Æ£¨°üÀ¨CAS²ÉÓõÄÃû³Æ£©¡¢ÆÕͨÃû³ÆºÍË×Ãû¡¢É̱꼰ÆäÓµÓÐÕß¡¢¹«Ë¾´úÂë¡¢CASµÇ¼ÇºÅ¡¢ÎïÀíºÍ¶¾ÀíÊý¾Ý¡¢ÖÎÁÆÓ¦Óá¢ÉÌÒµÓ¦Óõȡ£ÎÄÏ×ÀàÐͰüÀ¨»¯Ñ§ÎÄÏס¢ÉúÎïҽѧÎÄÏ׺ÍרÀûÎÄÏס£
     Ö÷ÌⷶΧ£ºÅ©Òµ»¯Ñ§£¨°üÀ¨Å©Ò©ºÍ³ýݬ¼Á£©¡¢ÉúÎïÖÆÆ·¡¢¾ßÓл·¾³ÒâÒåµÄ»¯ºÏÎï¡¢ÈËÀàÒ©Îï¡¢ÌìÈ»²úÆ·¡¢ÉÌÒµºÍÑо¿ÓõÄÓлúÎïÓëÎÞ»úÎï¡£

CA Search: Chemical Abstracts £¨ÃÀ¹ú»¯Ñ§ÎÄÕª£©
     ÓÉÃÀ¹ú»¯Ñ§ÎÄÕªÉçÌṩ£¬ÊÕ¼ÁË1967ÄêÒÔÀ´13Íò¶àƪÊÀ½ç¸÷µØµÄ»¯Ñ§¼°ÆäÓ¦Ó÷½ÃæµÄÎÄÏ×£¬°üÀ¨Ó¡Ë¢±¾CAµÄÊéÄ¿ÐÅÏ¢¡£»¯Ñ§ÎïÖÊÐëͨ¹ýCASµÇ¼ÇºÅ¼ìË÷£¬ÀàËÆÓÚÔÚDIALOG»¯Ñ§ÎïÖÊÎĵµÖмìË÷ÎïÖÊÐÅÏ¢£¬ÈçCHEMSEARCH£¨398Îĵµ£©¡£µÚ8´ÎÀÛ»ýË÷ÒýÒÔǰµÄ¼Ç¼¾ù¹éÈëµÚ399Îĵµ£¬¸ÃÎĵµµ½1997Äê12ÔÂÒÑÓÐ9.9Íò¶àÌõ¼Ç¼£»308-314Îĵµ·Ö±ð°üÀ¨ÁËÿһ´ÎµÄÀÛ»ýË÷Òý¡£

Drug Information Full Text £¨Ò©ÎïÐÅϢȫÎĿ⣩
     ¸Ã¿âµÄԭʼÐÅÏ¢À´Ô´ÓÚÃÀ¹úÒ½ÔºÒ©¼Áʦѧ»á³ö°æµÄÒÔÏÂÁ½ÖÖ³ö°æÎ
     ¢ÙAHFS£¨American Hospital Formulary Service£©Drug Information£¨°üÀ¨ÃÀ¹úÊг¡ÉÏ1000ÖÖÉÌÆ·Ò©ÎïÐÅÏ¢£©£»
     ¢ÚHandbook on Injectable Drugs£¨°üÀ¨211ÖÖÉÌÆ·Ò©ÎïºÍ57ÖÖÑо¿ÖеÄÒ©ÎïÐÅÏ¢£©¡£ÄÚÈݰüÀ¨Ò©ÎïÎȶ¨ÐÔ¡¢Ò©Îﻯѧ¡¢Ò©´ú¶¯Á¦Ñ§¡¢Ò©Îï·´Ó¦¡¢Ó÷¨¡¢¼ÁÁ¿¡¢Ò©Îï¹ÜÀí¡¢Ò©ÎïµÄÏàÈÝÐÔ¡¢ÌåÄÚ·´Ó¦ÒÔ¼°Ê¹ÓÃ×¢ÒâÊÂÏîµÈ·½Ã档ÿһÖÖÒ©Îï¶¼×¢Ã÷ÓÐÉÌÆ·Ãû¡¢»¯Ñ§Ãû¡¢ÖÆÔì³§¼Ò¡¢CASµÇ¼ÇºÅ¡¢ÖÎÁÆ·ÖÀàÒÔ¼°Ô­ÎÄÐÅÏ¢¡£
»Ø¸´´ËÂ¥
²»¶ÏµÄºÍ×Ô¼º½Ï¾¢°É£¡Îª×Ô¼ºÅ¬Á¦°É£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

­ZϪ

ºÃÌû°¡£¬¶¥Ò»ÏÂ
2Â¥2008-06-25 23:00:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ hongyangu µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 308Çóµ÷¼Á +6 īīĮ 2026-03-27 6/300 2026-03-27 15:20 by caszguilin
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á +3 RipcordÉϰ¶ 2026-03-27 3/150 2026-03-27 14:48 by ×íÔÚ·çÀï
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤°²È«¹¤³Ì300·Ö£¬Çóµ÷¼Á +4 0857Çóµ÷¼Á. 2026-03-24 4/200 2026-03-27 14:03 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] 305Çóµ÷¼Á +5 ÍÛ¬¿¨¿â 2026-03-26 5/250 2026-03-27 14:01 by laoshidan
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬335·Ö£¬0856£¬Çóµ÷¼ÁԺУºÍµ¼Ê¦ +4 Çã____Ïô 2026-03-27 5/250 2026-03-27 11:52 by zhshch
[¿¼ÑÐ] 316Çóµ÷¼Á +5 ½­´Ç666 2026-03-26 5/250 2026-03-27 08:08 by hypershenger
[¿¼ÑÐ] 304²ÄÁÏÇóµ÷¼Á +4 ÖÓllll 2026-03-26 4/200 2026-03-27 03:42 by wxiongid
[¿¼ÑÐ] 327Çóµ÷¼Á +7 prayer13 2026-03-23 7/350 2026-03-26 20:48 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ»¯Ñ§Ñ§Ë¶307Çóµ÷¼Á +8 y7czhao 2026-03-26 8/400 2026-03-26 19:51 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì 317Çóµ÷¼Á +4 JKSOIID 2026-03-26 4/200 2026-03-26 15:58 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 297Çóµ÷¼Á +6 ÌïºéÓÐ 2026-03-26 6/300 2026-03-26 15:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ¹¤´ó 081700 276Çóµ÷¼Á +4 µØÇòÈÆ×ÅÌ«Ñôת 2026-03-23 4/200 2026-03-26 14:27 by zzll406
[¿¼ÑÐ] 299Çóµ÷¼Á +4 15188958825 2026-03-25 4/200 2026-03-25 22:56 by 418490947
[¿¼ÑÐ] 0854È˹¤ÖÇÄÜ·½ÏòÕÐÊÕµ÷¼Á +4 ÕÂСÓã567 2026-03-24 4/200 2026-03-25 13:29 by 2177681040
[¿¼ÑÐ] 300·Ö£¬²ÄÁÏ£¬Çóµ÷¼Á£¬Ó¢Ò»Êý¶þ +5 ³¬ÔÞµÄ 2026-03-24 5/250 2026-03-24 21:07 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] µ÷¼Á +4 13853210211 2026-03-24 4/200 2026-03-24 19:44 by ms629
[¿¼ÑÐ] »¯¹¤×¨Ë¶Çóµ÷¼Á +3 questionÍì·ç 2026-03-24 3/150 2026-03-24 18:48 by jhhcooi
[¿¼²©] 26É격×Ô¼ö +3 whh869393 2026-03-24 3/150 2026-03-24 09:55 by 21018060
[¿¼ÑÐ] 384Çóµ÷¼Á +3 ×Óϵ²© 2026-03-22 6/300 2026-03-23 21:45 by ×Óϵ²©
[¿¼ÑÐ] 276Çóµ÷¼Á +3 YNRYG 2026-03-21 4/200 2026-03-23 08:31 by ×íÔÚ·çÀï
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û